Gunderson Dettmer advised Natera, Inc. in a follow-on public offering of 5,175,000 shares at the price to the public of $20.00 per share for a total of $103,500,000 in aggregate gross proceeds. Capital markets partner Richard Blake, corporate partner John Dietz and associates Owais Mahesri and Cathy Kwon led the team advising Natera.

The underwriting syndicate included J.P. Morgan, Morgan Stanley and Cowen.

Natera, which trades on the Nasdaq under the ticker symbol “NTRA,” is a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA.